Fri.Jul 26, 2024

article thumbnail

This week in drug discovery (22-26 July) 

Drug Discovery World

News round-up for 22-26 July by DDW Senior Digital Content Editor Diana Spencer. There have been some interesting developments in neuroscience this week. Perhaps most note-worthy, shingles vaccines Shingrix has been shown to reduce the risk of dementia by 17%, and TikoMed’s ALS drug caused a long-term slowing of ALS progression in a Phase II trial. The top stories: Oxford centre to address global epilepsy challenges The University of Oxford is launching The Centre for Global Epilepsy to address

Vaccine 130
article thumbnail

Researchers develop state-of-the-art device to make artificial intelligence more energy efficient

Science Daily: Pharmacology News

Engineering researchers have demonstrated a state-of-the-art hardware device that could reduce energy consumption for artificial intelligent (AI) computing applications by a factor of at least 1,000.

Research 130
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Novartis and Dren Bio partner on bispecific antibodies for cancer

Drug Discovery World

Dren Bio and Novartis Pharma have entered a strategic collaboration focused on the discovery and development of therapeutic bispecific antibodies for cancer. Under the terms of the agreement, Dren Bio will receive a total upfront consideration of $150 million from Novartis, which includes a $25 million equity investment in the company. Dren Bio is also eligible to receive up to $2.85 billion in additional cash payments upon achieving certain preclinical, clinical, regulatory, and commercial mile

Therapies 130
article thumbnail

'Dancing molecules' heal cartilage damage

Science Daily: Pharmacology News

New therapy uses synthetic nanofibers to mimic the natural signaling of a protein that is crucial for cartilage formation and maintenance. Researchers found that intensifying the motion of molecules within the nanofibers led to more components needed for regeneration. After just four hours, the treatment activated the gene expression necessary to generate cartilage.

Therapies 123
article thumbnail

How Machine Learning Drives Clinical Trial Efficiency

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

article thumbnail

Certain Abbott Blood Sugar Monitors May Give Incorrect Readings

Drugs.com

FRIDAY, July 26, 2024 -- Abbott has warned diabetes patients that some of its continuous blood sugar monitoring systems may need to be replaced because of inaccurate readings."Abbott has recently identified a small number of FreeStyle Libre 3.

116
116
article thumbnail

Lampreys possess a 'jaw-dropping' evolutionary origin

Science Daily: Pharmacology News

Lampreys are one of only two living jawless vertebrates Jaws are formed by a key stem cell population called the neural crest New research reveals the gene regulatory changes that may explain morphological differences between jawed and jawless vertebrates.

More Trending

article thumbnail

Celebrating Amarender Peddamalku’s Second Microsoft MVP Award

Perficient: Drug Development

Perficient is thrilled to announce that Amarender Peddamalku has been awarded the prestigious “Most Valuable Professional” (MVP) status in Business Applications by Microsoft for the second time. This achievement is especially significant, highlighting his continued excellence and commitment to the Microsoft community. Amarender Peddamalku serves as the Microsoft Modern Work practice lead and digital transformation leader at Perficient.

article thumbnail

Toxic Lead Found in Cinnamon Product, FDA Says

Drugs.com

FRIDAY, July 26, 2024 -- An additional cinnamon product sold in the United States has been found to contain high levels of lead, health officials are warning.In a health alert issued Thursday, the U.S. Food and Drug Administration said the ground.

article thumbnail

New understanding of fly behavior has potential application in robotics, public safety

Science Daily: Pharmacology News

Scientists have identified an automatic behavior in flies that helps them assess wind conditions -- its presence and direction -- before deploying a strategy to follow a scent to its source. The fact that they can do this is surprising -- can you tell if there's a gentle breeze if you stick your head out of a moving car? Flies aren't just reacting to an odor with a preprogrammed response: they are responding in context-appropriate manner.

94
article thumbnail

At-Home Colon Cancer Test Can Save Lives

Drugs.com

FRIDAY, July 26, 2024 -- A simple home screening test for colon cancer can reduce the risk of dying from the disease by 33%, a new study shows.Results indicate that undergoing annual at-home FIT (fecal immunochemical test) screening “is as good as g.

Disease 105
article thumbnail

Deliver Fast, Flexible Clinical Trial Insights with Spotfire

Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.

article thumbnail

Leqembi voted down by European regulators

BioPharma Drive: Drug Pricing

Eisai plans to appeal the EMA’s negative recommendation, hoping to break into a market analysts expect could eventually bring billions of dollars in sales for the Alzheimer’s drug.

article thumbnail

Your Odds for Accidental Gun Death Rise Greatly in Certain States

Drugs.com

FRIDAY, July 26, 2024 -- Americans' risk of dying in a firearm accident depends in large part on where they live in the United States, a new study finds.People in Southeastern states like Mississippi, Louisiana and Alabama run the greatest risk of.

104
104
article thumbnail

WorldwideEdge: Driving Innovation in Bioanalytical Lab Run Success Rates

Conversations in Drug Development Trends

At Worldwide Clinical Trials’ bioanalytical lab, we view challenges as opportunities to excel and set new standards. The path to drug approval is complex, with many variables and potential delays. That’s why our team is committed to continuous improvement through our initiative, WorldwideEdge, where we optimize everything from our processes to our teams’ performance for each drug development program.

article thumbnail

Boar's Head Recalls Liverwurst Tied to Listeria Outbreak

Drugs.com

FRIDAY, July 26, 2024 -- Boar's Head announced Friday that it was recalling all of its liverwurst products because they could be tainted with dangerous Listeria monocytogenes bacteria. "The company is also recalling additional deli meat products.

article thumbnail

Clinical Data Like You´ve Never Seen It Before: Why Spotfire Is the Leading Tool for Clinical Analytics

Clinical development organizations face a wide array of challenges when it comes to data, many of which can impact the operational effectiveness of their clinical trials. In this whitepaper, experts from Revvity Signals explore how solutions like TIBCO® Spotfire® enable better, more streamlined studies. The whitepaper also features a success story from Ambrx, a leading biopharmaceutical company, detailing how it has leveraged Spotfire to tackle data quality and collaboration challenges in clinic

article thumbnail

Cannabis and Cannabinoid Signaling: Research Gaps and Opportunities [Commentary]

ASPET

Cannabis and its products have been used for centuries for both medicinal and recreational purposes. The recent widespread legalization of cannabis has vastly expanded its use in the United States across all demographics except for adolescents. Meanwhile decades of research have advanced our knowledge of cannabis pharmacology and particularly of the endocannabinoid system with which the components of cannabis interact.

article thumbnail

Shingles Vaccine Could Lower Dementia Risk

Drugs.com

FRIDAY, July 26, 2024 -- Older people who avail themselves of the newest shingles vaccine could reap a hidden benefit: A significant drop in their odds of developing dementia.One expert applauded the new findings."Dementia isn’t an inevitable part o.

Vaccine 98
article thumbnail

Two biotechs cut staff; AbbVie weathers biosimilar threat

BioPharma Drive: Drug Pricing

Glycomimetics and Cue Biopharma both revealed layoffs. Elsewhere, AbbVie’s earnings impressed Wall Street and an FDA panel recommended changing testing requirements for some lung cancer drugs.

article thumbnail

Kids From Poorer Families Less Likely to Survive Cancer

Drugs.com

FRIDAY, July 26, 2024 -- Children from poor families are less likely to survive cancer, particularly if they are not white, a new study reports.A childhood cancer patient’s risk of dying within five years of their diagnosis increases 4% for every o.

98
article thumbnail

FDA’s new guidance on postapproval manufacturing changes for biosimilars focuses on current practice, new dosage forms

Agency IQ

BY LAURA DIANGELO, MPH , RACHEL COE, MSC Meeting a biosimilar user fee commitment, the FDA is expanding on its recommendations for biosimilar and interchangeable product applicants asking the FDA for post-approval manufacturing changes. The new draft guidance gives considerations for applicants seeking new dosage form or strengths, and those manufacturing the product in a facility with other versions of the biological product.

article thumbnail

Fake Oxycontin Pills Widespread and Potentially Deadly: Report

Drugs.com

FRIDAY, July 26, 2024 -- The rate at which young Americans are ending up in hospital ICUs after using fake Oxycontin pills spiked with fentanyl is soaring, especially in the U.S. West, a new report warns.Medical toxicology data from one unnamed.

article thumbnail

FDA finalizes guidance on electronic submissions for OTC products

Agency IQ

BY AMANDA CONTI FDA has fulfilled its commitment under the Over-the-Counter Monograph Drug User Fee (OMUFA) program to issue final guidance on how sponsors can electronically submit monographs and other documents. The final document reflects the agency’s efforts to develop reference guides for its upload portals. Fill out the form to read the full article.

FDA 59
article thumbnail

Double Mastectomy May Offer No Survival Benefit to Women With Breast Cancer

Drugs.com

FRIDAY, July 26, 2024 -- Women who are diagnosed with breast cancer in one breast, even in the early stages, sometimes opt for a double mastectomy, due to the fear that the cancer will migrate to the other breast.But that decision may not offer any.

97
article thumbnail

Top IVDR Notified Body concern: Lack of E.U. reference laboratories for high-risk diagnostics

Agency IQ

BY COREY JASEPH, MS, RAC The newly available May 2024 meetings of the Medical Device Coordination Group provide insight into the European Commission’s efforts to fully implement the European medical device and diagnostic regulations. AgencyIQ took a look at the doings of the group and its subcommittees that are most pertinent for device manufacturers.

article thumbnail

Bristol Myers’ beat completes strong week of pharma earnings

BioPharma Drive: Drug Pricing

All five large pharmaceutical companies to report earnings this week raised either their profit or revenue guidance for the year.

article thumbnail

EU executive consults on proposed update to PIC chemical lists

Agency IQ

BY SCOTT STEPHENS, MPA The European Commission’s latest update to the export and import of hazardous chemicals regulation, which implements the Rotterdam Convention on prior informed consent in the EU, adds 41 chemicals to the list of substances requiring export notification. Fill out the form to read the full article.

article thumbnail

The ancestor of all modern birds probably had iridescent feathers

Science Daily: Pharmacology News

Birds tend to be more colorful in the tropics, and scientists wanted to find out how they got there: if colorful feathers evolved in the tropics, or if tropical birds have brightly-colored ancestors that came to the region from somwhere else. Scientists built a database of 9,409 birds to explore the spread of color across the globe. They found that iridescent, colorful feathers originated 415 times across the bird tree of life, and in most cases, arose outside of the tropics -- and that the ance

52
article thumbnail

DSI to Attend Animal Health Corridor Summit in Kansas City, MO on August 26-27th

DS in Pharmatics

Date: July 26, 2024 Location: Kansas City, MO DSI, a renowned pharmaceutical and animal health industry leader, is thrilled to announce its participation in the upcoming Animal Health Corridor Summit on August 26-27, 2024.

article thumbnail

New tentative approval for Alembic drug dabigatran etexilate mesylate

Drug Patent Watch

Dabigatran etexilate mesylate is the generic ingredient in two branded drugs marketed by Alkem Labs Ltd, Apotex, Hetero Labs Ltd Iii, and Boehringer Ingelheim and, and is included in five NDAs.

Drugs 52
article thumbnail

UX in Universal Design Series: Key Principles for Physical Disabilities in Health Systems – 1

Perficient: Drug Development

Welcome to the new series on Usability and Experience (UX) in Universal Design! In this series, we will delve into the key principles that ensure inclusivity and accessibility for all users. Our first installment focuses on the essential usability and UX principles for individuals with physical disabilities. By understanding and implementing these principles, designers and developers can create environments, products, and services that are not only functional but also enjoyable for everyone, reg

article thumbnail

New patent for Springworks drug OGSIVEO

Drug Patent Watch

Annual Drug Patent Expirations for OGSIVEO Ogsiveo is a drug marketed by Springworks and is included in one NDA. It is available from one supplier. There are twenty-one patents protecting this drug.

Drugs 52
article thumbnail

Why Universal Design in Health Systems Matters for Future-Proofing Healthcare – 6

Perficient: Drug Development

Welcome to our new installment of our Universal Design and Health System blog series. In this edition, we will explore the critical role of Universal Design in future-proofing healthcare. As the healthcare landscape continues to evolve, it is essential to create systems and environments that are adaptable, resilient, and inclusive. Universal Design principles provide a framework for achieving these goals, ensuring that healthcare facilities can meet the diverse needs of current and future popula

article thumbnail

Conferences

KIF1A

KIF1A.ORG has had the privilege of supporting both in-person and virtual conferences with our scientific and family community members. These events offer a unique opportunity for all stakeholders to come together and connect. For many researchers, it is often their first time meeting a KAND patient face-to-face. Similarly, for families, it is frequently the first occasion to meet another KAND patient in person.

article thumbnail

The use of Predictive Oncology’s EndoPrep™ with FUJIFILM Wako’s PYROSTAR™ demonstrates the ability to reduce protein interference with a variety of common proteins.

Predictive Oncology

EndoPrep as a sample treatment system to be used with FUJIFILM PYROSTAR ES-F/Plate Download white paper here Interested in partnering with us? Please fill out the form below. The post The use of Predictive Oncology’s EndoPrep™ with FUJIFILM Wako’s PYROSTAR™ demonstrates the ability to reduce protein interference with a variety of common proteins. appeared first on Predictive Oncology.

article thumbnail

Screens, Tweens and Sleep: Study Uncovers Tips for Better Rest

Drugs.com

FRIDAY, July 26, 2024 -- Turning off smartphones is an important step in making sure tweens get the sleep they need, a new study says.Leaving a phone ringer on is associated with a 25% higher risk of sleep disturbance among tweens ages 11 and 12.

52